EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 288 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2021. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,463,000 | -38.3% | 15,740 | -40.6% | 0.01% | -31.2% |
| Q4 2020 | $2,372,000 | -24.4% | 26,477 | -12.8% | 0.02% | -23.8% |
| Q3 2020 | $3,137,000 | +41.8% | 30,363 | +8.5% | 0.02% | +16.7% |
| Q2 2020 | $2,212,000 | +29.2% | 27,977 | -5.4% | 0.02% | +12.5% |
| Q1 2020 | $1,712,000 | +1.8% | 29,577 | -5.1% | 0.02% | +33.3% |
| Q4 2019 | $1,682,000 | -18.5% | 31,177 | -21.0% | 0.01% | -7.7% |
| Q3 2019 | $2,064,000 | +0.6% | 39,477 | -7.1% | 0.01% | -7.1% |
| Q2 2019 | $2,052,000 | +145.5% | 42,477 | +156.8% | 0.01% | +133.3% |
| Q1 2019 | $836,000 | -23.1% | 16,540 | -9.8% | 0.01% | -33.3% |
| Q4 2018 | $1,087,000 | -27.5% | 18,340 | -19.5% | 0.01% | -18.2% |
| Q3 2018 | $1,500,000 | +90.6% | 22,780 | +46.2% | 0.01% | +120.0% |
| Q2 2018 | $787,000 | -15.0% | 15,580 | -11.4% | 0.01% | -16.7% |
| Q1 2018 | $926,000 | – | 17,580 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 25,250 | $784,000 | 2.30% |
| Global Alpha Capital Management Ltd. | 418,030 | $12,976,000 | 1.40% |
| AIMZ Investment Advisors, LLC | 70,588 | $2,191,000 | 1.05% |
| PALISADE CAPITAL MANAGEMENT, LP | 566,080 | $17,571,000 | 0.48% |
| RICE HALL JAMES & ASSOCIATES, LLC | 261,533 | $8,118,000 | 0.39% |
| EARNEST PARTNERS LLC | 1,844,621 | $57,257,000 | 0.38% |
| SummerHaven Investment Management, LLC | 14,476 | $449,000 | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,085,874 | $33,706,000 | 0.26% |
| Ridgewood Investments LLC | 10,004 | $311,000 | 0.24% |
| DUALITY ADVISERS, LP | 65,650 | $2,038,000 | 0.20% |